Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 E Nicollet Blvd
Ste 100
Burnsville, MN 55337Phone+1 952-892-7190Fax+1 952-892-7956
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2004 - 2007- UPMC Medical EducationResidency, Internal Medicine, 2001 - 2004
Grant Medical CollegeClass of 1999
Certifications & Licensure
MN State Medical License 2007 - 2025
CA State Medical License 2003 - 2021
PA State Medical License 2001 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Tolerability & long-term disease control by IGHV mutation status among CLL patients on ibrutinib arm of E1912.Tait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, Elisabeth Paietta, Susan M O'Brien M.D
Blood Advances. 2024-08-20 - 117 citationsLong-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.Tait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, Elisabeth M Paietta, Susan O'Brien
Blood. 2022-07-14 - 24 citationsMeasurable Residual Disease Does Not Preclude Prolonged Progression-free Survival in CLL Treated with Ibrutinib.Victoria Wang, Curtis A. Hanson, Renee C. Tschumper, Connie Lesnick, Esteban Braggio
Blood. 2021-08-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
